Relationship of the p22phox (CYBA) Gene Polymorphism C242T with Risk of Coronary Artery Disease: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Wu, Zhijun ^a   Lou, Yuqing ^b   Jin, Wei ^a   Liu, Yan ^a   Lu, Lin ^a   Chen, Qiujing ^a   Xie, Yucai ^a   Lu, Guoping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER RISK; CAUCASIAN; CORONARY ARTERY DISEASE; CYBA GENE; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; STUDY DESIGN;

CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84883518358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070885     Document Type: Article

References (64)

1. Terkelsen CJ, Vach W, (2010) Using biomarkers to prioritise patients with stable angina pectoris for bypass surgery. BMJ 340: b5414.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: 188-197.
3. Topol EJ, Smith J, Plow EF, Wang QK, (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15 Spec No 2: R117-123.
4. Griendling KK, FitzGerald GA, (2003) Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108: 1912-1916.
5. Griendling KK, FitzGerald GA, (2003) Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108: 2034-2040.
6. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148.
7. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH, (1990) Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86: 1729-1737.
8. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, et al. (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97: 135-137.
9. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, et al. (2004) Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 27: 303-307.
10. Shimokata K, Yamada Y, Kondo T, Ichihara S, Izawa H, et al. (2004) Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 172: 167-173.
11. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, et al. (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347: 1916-1923.
12. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ, (2000) A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86: 391-395.
13. Nikitin AG, Chistiakov DA, Minushkina LO, Zateyshchikov DA, Nosikov VV, (2010) Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart Vessels 25: 229-236.
14. Li A, Prasad A, Mincemoyer R, Satorius C, Epstein N, et al. (1999) Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 86: 57-61.
15. Fang S, Wang L, Jia C, (2010) Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis. Thromb Res 125: e197-201.
16. Mata-Balaguer T, de la Herran R, Ruiz-Rejon C, Ruiz-Rejon M, Garrido-Ramos MA, et al. (2004) Angiotensin-converting enzyme and p22(phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population. Int J Cardiol 95: 145-151.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
18. Vach W, Gerke O, Hoilund-Carlsen PF, (2012) Three principles to define the success of a diagnostic study could be identified. J Clin Epidemiol 65: 293-300.
19. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, et al. (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 57: e215-367.
20. Joensen AM, Jensen MK, Overvad K, Dethlefsen C, Schmidt E, et al. (2009) Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol 62: 188-194.
21. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, et al. (2011) 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123: e426-579.
22. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://wwwohrica/programs/clinical_epidemiology/oxfordasp Accessed 13 April 2013.
23. Cohn LD, Becker BJ, (2003) How meta-analysis increases statistical power. Psychol Methods 8: 243-253.
24. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
25. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
27. Biros E, Norman PE, Jones GT, van Rij AM, Yu G, et al. (2011) Meta-analysis of the association between single nucleotide polymorphisms in TGF-beta receptor genes and abdominal aortic aneurysm. Atherosclerosis 219: 218-223.
28. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
29. He M, Jiang C, Zheng H, Wang F, Yang M, et al. (2004) [Study on the relationship between the polymorphism of P22phox C242T, vitamin E and coronary heart disease]. Wei Sheng Yan Jiu 33: 443-446.
30. He MA, Cheng LX, Jiang CZ, Zeng HS, Wang J, et al. (2007) Associations of polymorphism of P22(phox) C242T, plasma levels of vitamin E, and smoking with coronary heart disease in China. Am Heart J 153: 640 e641-646.
31. Saha N, Sanghera DK, Kamboh MI, (1999) The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 29: 999-1002.
32. Reich D, Thangaraj K, Patterson N, Price AL, Singh L, (2009) Reconstructing Indian population history. Nature 461: 489-494.
33. Quintana-Murci L, Chaix R, Wells RS, Behar DM, Sayar H, et al. (2004) Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor. Am J Hum Genet 74: 827-845.
34. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, et al. (2004) Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 75: 966-978.
35. Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M, (2012) Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus. Thromb Res 130: e259-265.
36. Cai H, Duarte N, Wilcken DE, Wang XL, (1999) NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 29: 744-748.
37. Fan M, Kahonen M, Rontu R, Lehtinen R, Viik J, et al. (2006) The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study. Am Heart J 152: 538-542.
38. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W, (1999) The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145: 315-323.
39. Goliasch G, Wiesbauer F, Grafl A, Ponweiser E, Blessberger H, et al. (2011) The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (
40. Katakami N, Kaneto H, Matsuoka TA, Takahara M, Imamura K, et al. (2010) Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis 212: 534-538.
41. Macias-Reyes A, Rodriguez-Esparragon F, Caballero-Hidalgo A, Hernandez-Trujillo Y, Medina A, et al. (2008) Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radic Res 42: 82-92.
42. Morgan TM, Krumholz HM, Lifton RP, Spertus JA, (2007) Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. Jama 297: 1551-1561.
43. Najafi M, Alipoor B, Shabani M, Amirfarhangi A, Ghasemi H, (2012) Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD(P)H oxidase p22phox gene and severity of stenosis in coronary arteries. Gene 499: 213-217.
44. Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, et al. (2006) C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Markers 22: 167-173.
45. Niemiec P, Zak I, Wita K, (2007) The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 18: 339-346.
46. Stanger O, Renner W, Khoschsorur G, Rigler B, Wascher TC, (2001) NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin Physiol 21: 718-722.
47. Vasiliadou C, Tousoulis D, Antoniades C, Marinou K, Tentolouris C, et al. (2007) Genetic Polymorphism C242T On The p22-phox Subunit Of NADPH Oxidase, As A Risk Factor For Myocardial Infarction: Effects On Platelets Activation And Oxidized LDL levels. J Am Coll Cardiol 49: 339A-340A.
48. Zafari AM, Davidoff MN, Austin H, Valppu L, Cotsonis G, et al. (2002) The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 4: 675-680.
49. Lee WH, Hwang TH, Oh GT, Kwon SU, Choi YH, et al. (2001) Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vasc Med 6: 103-108.
50. Minet L, Moller S, Vach W, Wagner L, Henriksen JE, (2010) Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials. Patient Educ Couns 80: 29-41.
51. Colhoun HM, McKeigue PM, Davey Smith G, (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361: 865-872.
52. Attia J, Thakkinstian A, D'Este C, (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56: 297-303.
53. Hemminki K, Lorenzo Bermejo J, Forsti A, (2006) The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 7: 958-965.
54. Schaid DJ, Jacobsen SJ, (1999) Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 149: 706-711.
55. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, et al. (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322: 882-889.
56. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
57. Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, et al. (2012) The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 9: e1001212.
58. Munafo MR, Flint J, (2004) Meta-analysis of genetic association studies. Trends Genet 20: 439-444.
59. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283: 2008-2012.
60. Wu Z, Lou Y, Jin W, Liu Y, Lu L, et al. (2012) The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPARgamma2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-Analysis. PLoS One 7: e53105.
61. Wu Z, Lou Y, Jin W, Liu Y, Lu L, et al. (2012) The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARgamma) is associated with risk of coronary artery disease: a meta-analysis. Mol Biol Rep.
62. Rae J, Noack D, Heyworth PG, Ellis BA, Curnutte JT, et al. (2000) Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 96: 1106-1112.
63. Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, et al. (1996) Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem 271: 3667-3670.
64. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK, (1996) p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321.